
Healthcare / Pharmaceuticals · NSE
Established in September 2003, Chandan Healthcare Limited is a leading diagnostic network in North India, offering a wide range of pathology and radiology services. The company operates a flagship lab, seven central labs, 26 satellite centres, and over 300 collection centres across 23 cities in Uttar Pradesh and more than 19 in Uttarakhand. Its portfolio includes 1,496 tests covering routine pathology, specialized diagnostics, and advanced imaging such as X-rays, CT scans, MRIs, and ultrasounds. Supported by a team of radiologists, pathologists, and skilled professionals, Chandan Healthcare is dedicated to providing accurate, reliable, and accessible diagnostic services across its growing network.
Price Band
₹151 – ₹159
Issue Size
₹107 Cr
Lot Size
800 shares
GMP
Est. Listing
₹159
at current GMP
Subscribed
7.11x
overall
Open
10 Feb 2025
Close
12 Feb 2025
Allotment
13 Feb 2025
Refund
14 Feb 2025
Demat Credit
15 Feb 2025
Listing
17 Feb 2025
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹159
Band: ₹151 – ₹159
Estimated Listing Price
₹159
Upper price + GMP
Lot Size
800 shares
Min investment ₹1,27,200
Estimated Profit / Lot
₹0
800 × ₹0
Grey Market Premium trend
—
▲ 0 today
Updated 11 months ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 30 Oct 2025 | — | 0.0% | ₹159 |
| 12 Nov 2025 | — | 0.0% | ₹159 |
| 19 Nov 2025 | — | 0.0% | ₹159 |
| 25 Nov 2025 | — | 0.0% | ₹159 |
GMP is unofficial market data. Not a guarantee of listing performance.
Chandan Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹107.36 Crores. The shares are offered at a price band of ₹151 to ₹159 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 800 shares (approx. ₹1,27,200 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-02-15, while un-allotted funds or UPI block mandates will be released on 2025-02-14.
The latest grey market premium for Chandan Healthcare Limited IPO is ₹0, which indicates an expected listing price of ₹159.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.